A recent trial is the latest to suggest that GLP-1s aren't just for treating diabetes and obesity.

As the rate of GLP-1 prescriptions in the U.S. has risen, the obesity rate has dropped.

Ozempic and other semaglutide medications have been working wonders in terms of shedding pounds for many people.

Does losing weight by taking GLP-1 drugs such as Ozempic and Wegovy actually improve your risk of other diseases associated with obesity? New research led by scientists at the…

A recent trial is the latest to suggest that GLP-1s aren't just for treating diabetes and obesity.

GLP-1 drugs may curb addiction and craving, making some patients less likely to drink alcohol. It could ease anxiety, compulsive thinking and emotional distress | World News

From dramatic weight loss to dangerous side effects and fake Ozempic scams, here’s the truth about the GLP-1 craze gripping South Africa and Hollywood.

Many people prescribed GLP-1 drugs for type 2 diabetes (such as Victoza, Ozempic, or tirzepatide) stop taking them, but a surprising number later return to treatment. Researchers…

A massive study of more than 600,000 U.S. veterans suggests that popular GLP-1 drugs such as semaglutide may do far more than help with diabetes and weight loss—they could also…

The obesity treatment landscape is changing fast, with GLP-1 drugs opening the door to more effective care than ever before. Experts now envision a future where medications,…

A Rutgers study suggests GLP-1 drugs such as Ozempic and Wegovy may weaken the link between impulsive tendencies and violent behavior. The surprising finding hints that these…

Scientists have identified genetic variants that may make some people less responsive to GLP-1 drugs used to treat Type 2 diabetes. Roughly 10% of the population carries these…